Search results for "TRIAC"

showing 10 items of 203 documents

Habitat ecology of the smooth snake Coronella austriaca and its reptilian prey in the degraded bog with implications for artificial refuge surveys

2016

AbstractDiet preferences of the smooth snake (Coronella austriaca) being still controversial, we studied the overlap between its habitat and that of its potential reptilian prey species using the artificial refuge (ATR) method. The discriminant function analysis revealed that part of the smooth snake’s habitat niche is unused by one of its prey species – Zootoca vivipara. The smooth snake was recorded more often in places with high density of individuals of another lizard species – Anguis fragilis. Occasional data on snake diets supported the assumption that the latter species is a very important food item for the smooth snake in the study area. Our study estimated the minimum number of tim…

0106 biological sciencesEcologyEcologyLizardBiologybiology.organism_classification010603 evolutionary biology01 natural sciencesPopulation densityPredation010601 ecologyNatrixCoronella austriacaHabitat destructionHabitatbiology.animalAnimal Science and ZoologyAnguisZoology and Ecology
researchProduct

Evaluating the potential for evolutionary mismatch in Batesian mimics: A case study in the endangered smooth snake (Coronella austriaca)

2018

Many harmless organisms gain a survival advantage by mimicking venomous species. This is the case of the endangered smooth snake (Coronella austriaca), which mimics venomous vipers. Although this may protect the smooth snake against most of its natural predators, it may render them at greater risk of mortality from humans, who are more inclined to kill species, such as vipers, that they consider dangerous. This may cause an evolutionary mismatch, whereby humans may counteract the natural advantage of mimicry. We explore this possibility of evaluating the willingness of humans to kill smooth snakes versus the adder (Vipera berus), as well as their ability to discern them in the Åland Islands…

0106 biological sciencesvaroitusväriVIPeRVipera berusconflictEndangered specieskyyZoologyAposematismmatelijat010603 evolutionary biology01 natural sciencescomplex mixturesPredationkäärmeetCoronella austriacakangaskäärmeGeneticsaposematismkäyttäytyminenEcology Evolution Behavior and Systematicsbiologylajiensuojelu010604 marine biology & hydrobiologymimikrybiology.organism_classificationBatesian mimicrysaalistusreptilesbehaviourPerspectiveMimicryta1181ihminen-eläinsuhdepredationGeneral Agricultural and Biological SciencesPerspectivesEvolutionary Applications
researchProduct

Investigating mixotrophic metabolism in the model diatom Phaeodactylum tricornutum.

2017

Diatoms are prominent marine microalgae, interesting not only from an ecological point of view, but also for their possible use in biotechnology applications. They can be cultivated in phototrophic conditions, using sunlight as the sole energy source. Some diatoms, however, can also grow in a mixotrophic mode, wherein both light and external reduced carbon contribute to biomass accumulation. In this study, we investigated the consequences of mixotrophy on the growth and metabolism of the pennate diatom Phaeodactylum tricornutum , using glycerol as the source of reduced carbon. Transcriptomics, metabolomics, metabolic modelling and physiological data combine to indicate that glycerol affect…

0301 basic medicineGlycerol[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]LightMetabolic fluxBiologySettore BIO/19 - Microbiologia GeneralePhotosynthesisPhaeodactylum tricornutumGeneral Biochemistry Genetics and Molecular BiologyGlycerolipid03 medical and health sciencesNutrientmixotrophyBotanyMicroalgaeSettore BIO/04 - Fisiologia VegetaleMetabolomics[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biologyphotosynthèse14. Life underwaterPhaeodactylum tricornutumBiomassTranscriptomicsmétabolismemicro-algueDiatomsphotosynthesisPhototrophmarine diatomsfungiCarbon metabolismLipid metabolismArticlesapproche omiquebiology.organism_classificationCarbonTriacylglycerol biosynthesis030104 developmental biologyDiatomBiomass productionLipid metabolismBiochemistryGeneral Agricultural and Biological SciencesEnergy sourcemetabolismMixotrophomics analyses
researchProduct

Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6j mice fed trans-10, cis-12-linoleic acid

2003

AbstractConjugated linoleic acids (CLA) have recently been recognized to reduce body fat and plasma lipids in some animals. This study demonstrated that the steatosis accompanying the fat loss induced by trans-10,cis-12-C18:2 (CLA2) and not cis-9,trans-11-C18:2 (CLA1) isomer in C57BL/6j mice was not due to an alteration of the liver lipoprotein production that was even increased. The 3-fold decrease in plasma triacylglycerol contents and the induction of mRNA expression of low-density lipoprotein receptors concomitantly observed in CLA2-fed mice suggested an increase in the lipoprotein clearance at the level of the liver itself. CLA1 feeding produced similar but attenuated effects on trigly…

030309 nutrition & dieteticsConjugated linoleic acidLiver steatosisLipoproteins VLDLBiochemistrychemistry.chemical_compoundMiceStructural BiologyLipoproteinReceptorComputingMilieux_MISCELLANEOUSchemistry.chemical_classification0303 health sciencesFatty AcidsLiverlipids (amino acids peptides and proteins)Conjugated linoleic acidmedicine.medical_specialtyLinoleic acidBiophysics[SDV.BC]Life Sciences [q-bio]/Cellular BiologyTriacylglycerolLinoleic Acid03 medical and health sciencesInternal medicineGeneticsmedicineAnimalsLow-density lipoprotein receptorRNA MessengerMolecular BiologyTriglycerides030304 developmental biologyDNA PrimersBase SequenceEsterificationMyocardiumBody WeightRNAFatty acidCell BiologyFatty acidmedicine.diseaseFatty LiverMice Inbred C57BLEndocrinologychemistryLDL receptorSteatosisLipoprotein
researchProduct

CCDC 149238: Experimental Crystal Structure Determination

2001

Related Article: S.Mahboobi, I.Dechant, H.Reindl, H.Pongratz, A.Popp, D.Schollmeyer|2000|J.Heterocycl.Chem.|37|307|doi:10.1002/jhet.5570370215

431-Dimethyl-1414213134-hexaaoctacyclo(32.2.2.0-^26^.0^715^.0^813^.0^2028^.0^2227^.0^2933^)octatriaconta-2(6)7(15)8(13)91120(28)22(27)232529(33)-decaene-353032-tetraone tetrahydrofuran solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 777752: Experimental Crystal Structure Determination

2011

Related Article: Yuhui Kou, Hongqi Tao, Derong Cao, Zhiyong Fu, D.Schollmeyer, H.Meier|2010|Eur.J.Org.Chem.|2010|6464|doi:10.1002/ejoc.201000718

49141926-Pentabutoxy-2428303234-pentamethoxyhexacyclo[21.2.2.2^36^.2^811^.2^1316^.2^1821^]pentatriaconta-1(25)358101315182023262830323 4-pentadecaenebis(acetonitrile) clathrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 777751: Experimental Crystal Structure Determination

2011

Related Article: Yuhui Kou, Hongqi Tao, Derong Cao, Zhiyong Fu, D.Schollmeyer, H.Meier|2010|Eur.J.Org.Chem.|2010|6464|doi:10.1002/ejoc.201000718

49142628-pentabutoxy-1924303234-pentamethoxyhexacyclo[21.2.2.2^36^.2^811^.2^1316^.2^1821^]pentatriaconta-1(25)3581013151820232628303234-pentadecaene bis(acetonitrile) clathrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 258871: Experimental Crystal Structure Determination

2005

Related Article: V.Bohmer, B.Costisella, J.Gloede, S.Ozegowski, M.Schneider, I.Thondorf|2005|Eur.J.Org.Chem.|2005|2788|doi:10.1002/ejoc.200400906

51016212732-hexakis(t-Butyl)-heptacyclo[28.3.1.137.1812.11418.11923.12529]nonatriaconta-1(34)357(39)81012(38)141618(37)192123(36)252729(35)3032-octadecaene-343539:363738-diphosphateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 705738: Experimental Crystal Structure Determination

2009

Related Article: D.Meshcheryakov, V.Bohmer, M.Bolte, V.Hubscher-Bruder, F.Arnaud-Neu|2009|Chem.-Eur.J.|15|4811|doi:10.1002/chem.200802573

97979898-Tetramethyl-3435191-tetra-t-butyl-153147637995-hexaoxa-6822243840545670728688-dodeca-azapentadecacyclo[91.3.1.14549.0596.0914.01621.02530.03237.04146.04853.05762.06469.07378.08085.08994]octanonaconta-1(96)2491113161820252729323436414345485052575961646668737577808284899193-hexatriacontaene-72339557187-hexone acetonitrile ethanol ethyl acetate solvate monohydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.

2022

Funder: European Commission

ALTtype 2 diabetes mellitusROC receiving operator characteristicaspartate aminotransferaseHSDLDL low-density lipoproteinUHPLC ultrahigh-performance liquid chromatographyROCHCCNon-alcoholic steatohepatitisGCPCANASHGastroenterology2-HB 2-hydroxybutanoic acid; 3-HB 3-hydroxybutanoic acid; ALT alanine aminotransferase; AST aspartate aminotransferase; CE cholesterol ester; Cer ceramide; FFA free fatty acid; FLIP Fatty Liver Inhibition of Progression; Fibrosis; GC gas chromatography; HCC hepatocellular carcinoma; HSD honest significant difference; LC lipid cluster; LDL low-density lipoprotein; LM lipid and metabolite; LMC lipid metabolite and clinical variable; LPC lysophosphatidylcholine; Lipidomics; Mass spectrometry; Metabolomics; NAFL non-alcoholic fatty liver; NAFLD non-alcoholic fatty liver disease; NAS NASH activity score; NASH non-alcoholic steatohepatitis; NIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research Network; NRR non-rejection rate; Non-alcoholic steatohepatitis; PC(O) ether PC; PC phosphatidylcholine; PCA principal component analysis; PE phosphatidylethanolamine; QTOFMS quadrupole-time-of-flight mass spectrometry; ROC receiving operator characteristic; SAF steatosis activity and fibrosis; SM sphingomyelin; T2DM type 2 diabetes mellitus; TG triacylglycerol; UHPLC ultrahigh-performance liquid chromatographySAFSAF steatosis activity and fibrosisLM lipid and metabolitehonest significant differenceHSD honest significant differenceTG triacylglycerolnon-rejection ratecholesterol esterPCPEGC gas chromatographyfree fatty acidFLIPNASH non-alcoholic steatohepatitisNIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research NetworkBIOMARKERST2DMPE phosphatidylethanolamineLDLlipidNAFLDFFA free fatty acid2-HBMetabolomicsNAFL non-alcoholic fatty liverLMCphosphatidylcholineScience & TechnologySM sphingomyelinGastroenterology & HepatologyMass spectrometryactivitynutritional and metabolic diseasesT2DM type 2 diabetes mellitusACIDSreceiving operator characteristicdigestive system diseasesquadrupole-time-of-flight mass spectrometryLC lipid clusterlow-density lipoproteinNAS2-HB 2-hydroxybutanoic acidNAS NASH activity scoreQTOFMSether PCNRRSCORING SYSTEMprincipal component analysisgas chromatographyLC2-hydroxybutanoic acidPROGRESSIONAST aspartate aminotransferaseLMPC phosphatidylcholinePC(O)MARKERSUHPLCsteatosisTOOLImmunology and AllergyINSULIN-RESISTANCECerSMFatty Liver Inhibition of Progressionhepatocellular carcinoma2-HB 2-hydroxybutanoic acid NIDDK NASH-CRN National Institute of Digestive Diseases and Kidney NASH Clinical Research Network NRR non-rejection rate Non-alcoholic steatohepatitis PC(O) ether PC PC phosphatidylcholine PCA principal component analysis PE phosphatidylethanolamine QTOFMS quadrupole-time-of-flight mass spectrometry ROC receiving operator characteristic SAF steatosis activity and fibrosis SM T2DM type 2 diabetes mellitus TG triacylglycerol UHPLC ultrahigh-performance liquid chromatographyultrahigh-performance liquid chromatographyCELPC3-HBNAFLnon-alcoholic fatty liverTGtriacylglycerolNRR non-rejection rateLife Sciences & BiomedicineNAFLD non-alcoholic fatty liver diseaseFLIP Fatty Liver Inhibition of Progressionalanine aminotransferasemetaboliteCer ceramideCE cholesterol estersphingomyelinlysophosphatidylcholineand fibrosisALT alanine aminotransferaseInternal MedicineceramideNational Institute of Digestive Diseases and Kidney NASH Clinical Research NetworkAST3-HB 3-hydroxybutanoic acidQTOFMS quadrupole-time-of-flight mass spectrometryPCA principal component analysisLPC lysophosphatidylcholineHepatologynon-alcoholic fatty liver diseaseand clinical variablePC(O) ether PC3-hydroxybutanoic acidFibrosisNASH activity scoreNIDDK NASH-CRNlipid clusterlipid and metabolitephosphatidylethanolamineLipidomicsLMC lipid metabolite and clinical variableFFAHCC hepatocellular carcinomaJHEP reports : innovation in hepatology
researchProduct